May 26, 2017 12:01 pm UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, May 26, 2017 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced an oral presentation, as well as four trials in progress...
Asta Funding Announces Results for the Second Quarter Ended March 31, 2017
May 26, 2017 12:00 pm UTC| Business
Simia Capital commences operations in January, completes the purchase of a $3 million personal injury claims portfolio$18 million collected in May 2017 from claimants in the Company's personal injury claims segmentCBC...
AHRQ Research Reveals Massage, Sensory Interventions Improve Autism Behaviors
May 26, 2017 11:53 am UTC| Business
Rockville, MD, May 26, 2017 -- Sensory-focused interventions – such as massage, swinging and trampoline exercises and exposure to different textures – reduced sensory and motor impairments in children with autism...
Aduro Biotech to Host and Webcast an Investor Event in Conjunction with the 2017 ASCO Annual Meeting
May 26, 2017 11:05 am UTC| Business
BERKELEY, Calif., May 26, 2017 -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that the Aduro management team will host an investor event with special guest speaker Jason J. Luke, M.D., FACP, Assistant Professor of...
Assembly Biosciences Announces June Conference Presentations
May 26, 2017 11:02 am UTC| Business
INDIANAPOLIS, May 26, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...
Assembly Biosciences Announces June Conference Presentations
May 26, 2017 11:02 am UTC| Business
INDIANAPOLIS, May 26, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...
Assembly Biosciences Announces June Conference Presentations
May 26, 2017 11:02 am UTC| Business
INDIANAPOLIS, May 26, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...
Trump Administration Files Fraud Charges Against Southern Poverty Law Center Over Informant Payments